BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10535539)

  • 1. Etiology of fibrous dysplasia and McCune-Albright syndrome.
    Cohen MM; Howell RE
    Int J Oral Maxillofac Surg; 1999 Oct; 28(5):366-71. PubMed ID: 10535539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
    Lietman SA; Ding C; Levine MA
    J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. McCune-Albright syndrome and disorders due to activating mutations of GNAS1.
    Diaz A; Danon M; Crawford J
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):853-80. PubMed ID: 17937059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular basis of fibrous dysplasia.
    Marie PJ
    Histol Histopathol; 2001 Jul; 16(3):981-8. PubMed ID: 11510989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the GSalpha gene in the diagnosis of fibrous dysplasia.
    Perdigão PF; Pimenta FJ; Castro WH; De Marco L; Gomez RS
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):498-501. PubMed ID: 15183415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of genetic defects in G proteins: oncogenic mutations in G alpha s as the molecular basis for the McCune-Albright syndrome.
    Levine MA
    Arch Med Res; 1999; 30(6):522-31. PubMed ID: 10714367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
    Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
    N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: : GNAS-activating mutations in pancreatic carcinogenesis.
    Parvanescu A; Cros J; Ronot M; Hentic O; Grybek V; Couvelard A; Levy P; Chanson P; Ruszniewski P; Sauvanet A; Gaujoux S
    JAMA Surg; 2014 Aug; 149(8):858-62. PubMed ID: 24898823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.
    Riminucci M; Fisher LW; Shenker A; Spiegel AM; Bianco P; Gehron Robey P
    Am J Pathol; 1997 Dec; 151(6):1587-600. PubMed ID: 9403710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel GNAS1 mutation, R201G, in McCune-albright syndrome.
    Riminucci M; Fisher LW; Majolagbe A; Corsi A; Lala R; De Sanctis C; Robey PG; Bianco P
    J Bone Miner Res; 1999 Nov; 14(11):1987-9. PubMed ID: 10571700
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.
    Marie PJ; de Pollak C; Chanson P; Lomri A
    Am J Pathol; 1997 Mar; 150(3):1059-69. PubMed ID: 9060842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.
    Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
    J Mol Diagn; 2000 May; 2(2):67-72. PubMed ID: 11272890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of McCune-Albright syndrome.
    de Sanctis L; Delmastro L; Russo MC; Matarazzo P; Lala R; de Sanctis C
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():577-82. PubMed ID: 16789620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
    Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
    J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian dysfunction by activating mutation of GS alpha: McCune-Albright syndrome as a model.
    Chanson P; Salenave S; Young J
    Ann Endocrinol (Paris); 2010 May; 71(3):210-3. PubMed ID: 20362972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and molecular aspects of McCune-Albright syndrome.
    Lietman SA; Schwindinger WF; Levine MA
    Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():380-5. PubMed ID: 17982384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of McCune-Albright syndrome associated with Gs alpha mutation in the bone tissue.
    Sargin H; Gozu H; Bircan R; Sargin M; Avsar M; Ekinci G; Yayla A; Gulec I; Bozbuga M; Cirakoglu B; Tanakol R
    Endocr J; 2006 Feb; 53(1):35-44. PubMed ID: 16543670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome.
    Weinstein LS
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P120-4. PubMed ID: 17229000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrous dysplasia.
    Lietman SA; Levine MA
    Pediatr Endocrinol Rev; 2013 Jun; 10 Suppl 2():389-96. PubMed ID: 23858622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy.
    Ringel MD; Schwindinger WF; Levine MA
    Medicine (Baltimore); 1996 Jul; 75(4):171-84. PubMed ID: 8699958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.